References
- 1. SITAR TAUT AV., POP D., ZDRENGHEA DT. NT-probnp values in elderly heart failure patients with atrial fibrillation and diabetes. J Diabetes Complications. 2015; 29(8):1119-23.
- 2. DEO R., DE LEMOS JA. B-type natriuretic peptide in ischemic heart disease. Curr Cardiol Rep. 2003; 5(4):271-7.
- 3. LUCHNER A., STEVENS TL., BORGESON DD., REDFIELD M., WEI CM., PORTER JG., et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol. 1998; 274(5 Pt 2):H1684-9.
- 4. POPELOVA JR., KOTASKA K., TOMKOVA M., TOMEK J. Usefulness of N-terminal-pro-Brain Natriuretic Peptide to predict mortality in adults with congenital heart disease. Am J Cardiol. 2015; 116(9):1425-30.
- 5. HEDBERG P., SELMERYD J., LEPPERT J., HENRIKSEN E. Left atrial minimum volume is more strongly associated with Nterminal pro-B-type natriuretic peptide than the left atrial maximum volume in a community-based sample. Int J Cardiovasc Imaging. 2016; 32(3):417-25.
- 6. SIVA SANKARA C., RAJASEKHAR D., VANAJAKSHAMMA V., PRAVEEN KUMAR BS., VAMSIDHAR A. Prognostic significance of NT-probnp, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention. Indian Heart J. 2015; 67(4):318-27.
- 7. EINDHOVEN JA., VAN DEN BOSCH AE., RUYS TP., OPIC P., CUYPERS JA., MCGHIE JS., et al. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol. 2013; 62(13):1203-12.
- 8. BISSESSOR N., WEE YS., JAYASINGHE R., ZENG I., LOWE B., KOLBE J., et al. Complimentary roles for N-terminal pro-B-type natriuretic peptide and spirometry to assess functional capacity in patients with complex mixed heart valve disease. Kardiol Pol. 2010; 68(1):1-10.
- 9. POURAFKARI L., SEYEDHOSSEINI S., KAZEMI B., ESMAILI H., ASLANABADI N. Changes in serum NT-pro-BNP and left atrial BNP levels after percutaneous transvenous mitral commissurotomy in sinus rhythm versus atrial fibrillation. J Cardiovasc Thorac Res. 2014; 6(3):175-9.
- 10. RAMAKRISHNAN S., AGARWAL A., SINGH S., KARTHIKEYAN G., SETH S., NARANG R., et al. NT-pro-BNP levels as a marker of success of percutaneous transvenous mitral commissurotomy. Indian Heart J. 2010; 62(1):35-8.
- 11. ARAT-OZKAN A., KAYA A., YIGIT Z., BALCI H., OKCUN B., YAZICIOGLU N., et al. Serum N-terminal pro-BNP levels correlate with symptoms and echocardiographic findings in patients with mitral stenosis. Echocardiography. 2005; 22(6):473-8.
- 12. ERYOL NK., DOGAN A., OZDOGRU I., INANC MT., KAYA MG., KALAY N. The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis. Int J Cardiovasc Imaging. 2007; 23(5):569-74.
- 13. ILTUMUR K., KARABULUT A., YOKUS B., YAVUZKIR M., TASKESEN T., TOPRAK N. N-terminal pro-BNP plasma levels correlate with severity of mitral stenosis. J Heart Valve Dis. 2005; 14(6):735-41.
- 14. UCAR O., BAYAR N., KARAGOZ A., AYDOGDU S. Valvular heart disease: plasma B-type natriuretic peptide levels in patients with pure rheumatic mitral stenosis. Acta Cardiol. 2012; 67(1):59-64.
- 15. ESMAEILZADEH M., NIKPARVAR M., MALEKI M., NOOHI F., OJAGHI HAGHIGHI Z., SAMIEI N., et al. Assessment of inter and intra-atrial asynchrony in patients with systolic heart failure using velocity vector imaging. Res Cardiovasc Med. 2013; 2(3):114-20.
- 16. BUOB A., JUNG J., SIAPLAOURAS S., NEUBERGER HR., MEWIS C. Discordant regulation of CRP and NT-probnp plasma levels after electrical cardioversion of persistent atrial fibrillation. Pacing Clin Electrophysiol. 2006; 29(6):559-63.
- 17. DANICEK V., THEODOROVICH N., BAR-CHAIM S., MILLER A., VERED Z., KOREN-MORAG N., et al. Sinus rhythm restoration after atrial fibrillation: the clinical value of N-terminal pro-BNP measurements. Pacing Clin Electrophysiol. 2008; 31(8):955-60.
- 18. MOLLMANN H., WEBER M., ELSASSER A., NEF H., DILL T., RIXE J., et al. NT-pro-BNP predicts rhythm stability after cardioversion of lone atrial fibrillation. Circ J. 2008; 72(6):921-5.
- 19. SHIN DI., JAEKEL K., SCHLEY P., SAUSE A., MULLER M., FUETH R., et al. Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Z Kardiol. 2005; 94(12):795-800.
- 20. TSUCHIDA K., TANABE K. Influence of paroxysmal atrial fibrillation attack on brain natriuretic peptide secretion. J Cardiol. 2004; 44(1):1-11.
- 21. RANGANAYAKULU KP., RAJASEKHAR D., VANAJAKSHAMMA V., SANTOSH KUMAR C., VASUDEVA CHETTY P. N-terminal-pro-brain natriuretic peptide, a surrogate biomarker of combined clinical and hemodynamic outcomes following percutaneous transvenous mitral commissurotomy. J Saudi Heart Assoc. 2016; 28(2):81-8.
- 22. CHADHA DS., KARTHIKEYAN G., GOEL K., MALANI SK., SETH S., SINGH S., et al. N-terminal pro-BNP plasma levels before and after percutaneous transvenous mitral commissurotomy for mitral stenosis. Int J Cardiol. 2010; 144(2):238-40.